MedTrace Logo

A Pharmacokinetic Study of Three Different Particle Sizes of PH-797804

NCT01924650 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2013-12-20

No results posted yet for this study

Summary

The purpose of this study is to investigate the effects of varying particle size on the pharmacokinetics of PH-797804

Conditions

  • Healthy

Interventions

DRUG

PH-797804

Tablet, 6 mg, single dose

DRUG

PH-797804

Tablet, 6 mg, single dose

DRUG

PH-797804

Tablet, 6 mg, single dose

DRUG

PH-797804

Tablet, 6 mg, single dose

DRUG

PH-797804

Tablet, 6 mg, single dose

DRUG

PH-797804

Tablet, 6 mg, single dose

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2014-06-30
Completion
2014-06-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01924650 on ClinicalTrials.gov